Free Trial

OrthoPediatrics Corp. (NASDAQ:KIDS) Shares Sold by Brown Capital Management LLC

OrthoPediatrics logo with Medical background

Brown Capital Management LLC cut its holdings in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 13.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,241,920 shares of the company's stock after selling 351,848 shares during the quarter. OrthoPediatrics accounts for approximately 1.3% of Brown Capital Management LLC's investment portfolio, making the stock its 28th largest position. Brown Capital Management LLC owned 9.26% of OrthoPediatrics worth $60,778,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. International Assets Investment Management LLC grew its stake in shares of OrthoPediatrics by 2,610.8% during the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company's stock valued at $27,000 after buying an additional 966 shares during the last quarter. Quest Partners LLC bought a new stake in OrthoPediatrics during the 2nd quarter valued at about $34,000. EntryPoint Capital LLC boosted its position in OrthoPediatrics by 56.9% in the 1st quarter. EntryPoint Capital LLC now owns 2,783 shares of the company's stock valued at $81,000 after buying an additional 1,009 shares during the period. SG Americas Securities LLC bought a new position in OrthoPediatrics in the 2nd quarter worth about $110,000. Finally, State Board of Administration of Florida Retirement System bought a new stake in shares of OrthoPediatrics during the first quarter valued at approximately $178,000. Hedge funds and other institutional investors own 69.05% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on KIDS shares. JMP Securities reissued a "market outperform" rating and issued a $50.00 price objective on shares of OrthoPediatrics in a research note on Friday, September 13th. Needham & Company LLC reiterated a "buy" rating and set a $42.00 target price on shares of OrthoPediatrics in a report on Friday, November 8th. Finally, Truist Financial reduced their price target on shares of OrthoPediatrics from $34.00 to $28.00 and set a "hold" rating for the company in a report on Monday, October 14th.

View Our Latest Stock Report on OrthoPediatrics

OrthoPediatrics Stock Up 3.8 %

KIDS stock traded up $0.96 during trading on Thursday, reaching $26.46. 141,733 shares of the company traded hands, compared to its average volume of 169,186. The company has a market capitalization of $640.86 million, a price-to-earnings ratio of -21.24 and a beta of 1.16. The business has a 50 day simple moving average of $26.67 and a 200 day simple moving average of $29.42. OrthoPediatrics Corp. has a 12 month low of $22.41 and a 12 month high of $36.23. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17.

About OrthoPediatrics

(Free Report)

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

Featured Articles

Institutional Ownership by Quarter for OrthoPediatrics (NASDAQ:KIDS)

Should you invest $1,000 in OrthoPediatrics right now?

Before you consider OrthoPediatrics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OrthoPediatrics wasn't on the list.

While OrthoPediatrics currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines